Klaus Borner

1.5k total citations
33 papers, 1.1k citations indexed

About

Klaus Borner is a scholar working on Pharmacology, Epidemiology and Molecular Medicine. According to data from OpenAlex, Klaus Borner has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pharmacology, 12 papers in Epidemiology and 6 papers in Molecular Medicine. Recurrent topics in Klaus Borner's work include Antibiotics Pharmacokinetics and Efficacy (20 papers), Pneumonia and Respiratory Infections (8 papers) and Antibiotic Resistance in Bacteria (6 papers). Klaus Borner is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (20 papers), Pneumonia and Respiratory Infections (8 papers) and Antibiotic Resistance in Bacteria (6 papers). Klaus Borner collaborates with scholars based in Germany, United States and France. Klaus Borner's co-authors include H. Lode, P. Koeppe, Annette Lubasch, Oliver Liesenfeld, Rainer Müller, Helmut Hahn, Rudolf Fitzner, Oliver Kayser, Joachim Hoyer and Ivica Grgic and has published in prestigious journals such as Circulation, The American Journal of Medicine and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Klaus Borner

33 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Klaus Borner Germany 16 392 293 222 123 121 33 1.1k
I. Nilsson-Ehle Sweden 24 865 2.2× 195 0.7× 357 1.6× 216 1.8× 318 2.6× 58 1.8k
Olivier Petitjean France 22 667 1.7× 225 0.8× 450 2.0× 246 2.0× 330 2.7× 89 1.6k
Lee B. Barradell 18 323 0.8× 165 0.6× 257 1.2× 181 1.5× 155 1.3× 24 1.3k
R. S. Griffith United States 20 305 0.8× 180 0.6× 255 1.1× 201 1.6× 129 1.1× 35 1.0k
Sylvie Saivin France 23 600 1.5× 160 0.5× 366 1.6× 112 0.9× 278 2.3× 75 1.7k
P Periti Italy 21 450 1.1× 283 1.0× 505 2.3× 216 1.8× 175 1.4× 107 1.9k
John G. Gambertoglio United States 31 572 1.5× 320 1.1× 648 2.9× 565 4.6× 135 1.1× 91 2.4k
William R. Ravis United States 20 306 0.8× 271 0.9× 66 0.3× 54 0.4× 105 0.9× 116 1.4k
James Longstreth United States 23 601 1.5× 415 1.4× 367 1.7× 242 2.0× 74 0.6× 40 2.2k
Jane C. Gillis 12 168 0.4× 247 0.8× 174 0.8× 69 0.6× 21 0.2× 15 1.3k

Countries citing papers authored by Klaus Borner

Since Specialization
Citations

This map shows the geographic impact of Klaus Borner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Borner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Borner more than expected).

Fields of papers citing papers by Klaus Borner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Borner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Borner. The network helps show where Klaus Borner may publish in the future.

Co-authorship network of co-authors of Klaus Borner

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Borner. A scholar is included among the top collaborators of Klaus Borner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Borner. Klaus Borner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dunay, Ildikò Rita, Margitta Dathe, Rachmat Mauludın, et al.. (2009). The role of apolipoprotein E in uptake of atovaquone into the brain in murine acute and reactivated toxoplasmosis. Journal of drug targeting. 17(4). 257–267. 28 indexed citations
2.
Schwartz, Stefan, Klaus Borner, Peter Martus, et al.. (2007). Glucarpidase (Carboxypeptidase G2) Intervention in Adult and Elderly Cancer Patients with Renal Dysfunction and Delayed Methotrexate Elimination After High-Dose Methotrexate Therapy. The Oncologist. 12(11). 1299–1308. 69 indexed citations
3.
Burkhardt, Olaf, Heino Staß, Uwe Thuß, Klaus Borner, & Tobias Welte. (2005). Effects of Enteral Feeding on the Oral Bioavailability of Moxifloxacin in Healthy Volunteers. Clinical Pharmacokinetics. 44(9). 969–976. 16 indexed citations
4.
Köhler, Ralf, Heike Wulff, Ines Eichler, et al.. (2003). Blockade of the Intermediate-Conductance Calcium-Activated Potassium Channel as a New Therapeutic Strategy for Restenosis. Circulation. 108(9). 1119–1125. 207 indexed citations
5.
Burkhardt, Olaf, Klaus Borner, Heino Staß, et al.. (2002). Single- and Multiple-dose Pharmacokinetics of Oral Moxifloxacin and Clarithromycin, and Concentrations in Serum, Saliva and Faeces. Scandinavian Journal of Infectious Diseases. 34(12). 898–903. 31 indexed citations
6.
Borner, Klaus, et al.. (2001). Determination of linezolid in human serum and urine by high-performance liquid chromatography. International Journal of Antimicrobial Agents. 18(3). 253–258. 70 indexed citations
7.
Borner, Klaus, et al.. (1999). HPLC determination of clofazimine in tissues and serum of mice after intravenous administration of nanocrystalline or liposomal formulations. International Journal of Antimicrobial Agents. 11(1). 75–79. 12 indexed citations
8.
Reidenberg, Bruce E., et al.. (1999). Changes in fecal flora and comparative multiple-dose pharmacokinetics of ceftibuten, cefpodoxime proxetil and amoxycillin/clavulanate. Clinical Microbiology and Infection. 5(6). 339–354. 9 indexed citations
9.
Borner, Klaus, et al.. (1999). Determination of trovafloxacin in human body fluids by high-performance liquid chromatography. Journal of Chromatography A. 846(1-2). 175–180. 15 indexed citations
10.
Lode, H., et al.. (1996). Comparative pharmacokinetics of macrolide antibiotics and concentrations achieved in polymorphonuclear leukocytes and saliva. Clinical Microbiology and Infection. 1(4). 235–243. 12 indexed citations
11.
Borner, Klaus, et al.. (1993). Determination of a new cephalosporin, SCE-2787, in serum and urine by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 615(1). 174–179. 6 indexed citations
12.
Borner, Klaus, et al.. (1992). Determination of sparfloxacin in serum and urine by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 579(2). 285–289. 33 indexed citations
13.
Kampf, D., et al.. (1991). Multiple-Dose-Kinetics of Ofloxacin after Intraperitoneal Application in CAPD Patients. Peritoneal Dialysis International. 11(4). 317–321. 5 indexed citations
14.
Ruhnke, Markus, Matthias Trautmann, Klaus Borner, & W. Hopfenmüller. (1990). Pharmacokinetics of Ciprofloxacin in Liver Cirrhosis. Chemotherapy. 36(6). 385–391. 10 indexed citations
15.
Kunzendorf, Ulrich, Frieder Keller, Gerd Walz, et al.. (1989). Multivariate Analysis of Aminoglycoside Levels in Hemodialysis Patients. Chemotherapy. 35(1). 1–6. 5 indexed citations
16.
Lode, H., G. Höffken, Klaus Borner, & P. Koeppe. (1989). Ciprofloxacin intravenous dose variance. The American Journal of Medicine. 87(5). S40–S45. 2 indexed citations
17.
Pommer, Wolfgang, Elisabeth Bronder, Eberhard Greiser, et al.. (1989). Regular Analgesic Intake and the Risk of End-Stage Renal Failure. American Journal of Nephrology. 9(5). 403–412. 79 indexed citations
18.
Deppermann, Karl-Matthias, Michael Boeckh, Klaus Borner, et al.. (1989). Brief report: Combination effects of ciprofloxacin, clindamycin, and metronidazole intravenously in volunteers. The American Journal of Medicine. 87(5). S46–S48. 5 indexed citations
19.
Keller, Frieder, Karl Wagner, Klaus Borner, et al.. (1986). Aminoglycoside Dosage in Hemodialysis Patients. The Journal of Clinical Pharmacology. 26(8). 690–695. 5 indexed citations
20.
Marre, R., Klaus Borner, & E. Schulz. (1984). Different mechanisms of TEM-1 and Oxa-1 mediated resistance to piperacillin in E. coli. Zentralblatt für Bakteriologie Mikrobiologie und Hygiene Series A Medical Microbiology Infectious Diseases Virology Parasitology. 258(2-3). 287–295. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by I. Nilsson-Ehle Breakdown of academic impact, for papers by Olivier Petitjean Breakdown of academic impact, for papers by Lee B. Barradell Breakdown of academic impact, for papers by R. S. Griffith Breakdown of academic impact, for papers by Sylvie Saivin Breakdown of academic impact, for papers by P Periti Breakdown of academic impact, for papers by John G. Gambertoglio Breakdown of academic impact, for papers by William R. Ravis Breakdown of academic impact, for papers by James Longstreth Breakdown of academic impact, for papers by Jane C. Gillis
Rankless by CCL
2026